Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Orsolini

Showing results (71-80 of 73) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 73 results.
Arthritis & Rheumatology (Hoboken, N.J.)|August 28, 2023
The 2023 ACR/EULAR Antiphospholipid Syndrome Classification CriteriaMedha Barbhaiya, Stephane Zuily, Ray Naden, et al.
Annals of the Rheumatic Diseases|August 28, 2023
2023 ACR/EULAR antiphospholipid syndrome classification criteriaMedha Barbhaiya, Stephane Zuily, Ray Naden, et al.
Clinical and Experimental Rheumatology|February 24, 2022
Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodiesLorenzo Cavagna, Federica Meloni, Alain Meyer, et al.
Pageof 8

Showing results (71-80 of 73) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 73 results.
Arthritis & Rheumatology (Hoboken, N.J.)|August 28, 2023
The 2023 ACR/EULAR Antiphospholipid Syndrome Classification CriteriaMedha Barbhaiya, Stephane Zuily, Ray Naden, et al.
Annals of the Rheumatic Diseases|August 28, 2023
2023 ACR/EULAR antiphospholipid syndrome classification criteriaMedha Barbhaiya, Stephane Zuily, Ray Naden, et al.
Clinical and Experimental Rheumatology|February 24, 2022
Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodiesLorenzo Cavagna, Federica Meloni, Alain Meyer, et al.
Pageof 8